These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 3807893

  • 1. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
    Martino-Barrows AM, Kellar KJ.
    Mol Pharmacol; 1987 Feb; 31(2):169-74. PubMed ID: 3807893
    [Abstract] [Full Text] [Related]

  • 2. [3H]acetylcholine binding sites in brain. Effect of disulfide bond modification.
    Schwartz RD, Kellar KJ.
    Mol Pharmacol; 1983 Nov; 24(3):387-91. PubMed ID: 6633505
    [Abstract] [Full Text] [Related]

  • 3. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
    Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC.
    Mol Pharmacol; 1986 Nov; 30(5):427-36. PubMed ID: 3534542
    [Abstract] [Full Text] [Related]

  • 4. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM, Yaksh TL, Taylor P.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [Abstract] [Full Text] [Related]

  • 5. Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin.
    Yamada S, Isogai M, Kagawa Y, Takayanagi N, Hayashi E, Tsuji K, Kosuge T.
    Mol Pharmacol; 1985 Aug; 28(2):120-7. PubMed ID: 2862574
    [Abstract] [Full Text] [Related]

  • 6. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
    Costa LG, Murphy SD.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853
    [Abstract] [Full Text] [Related]

  • 7. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM, Terry AV.
    Neuroscience; 2005 Aug; 130(4):997-1012. PubMed ID: 15652996
    [Abstract] [Full Text] [Related]

  • 8. Endogenous material in brain inhibiting [3H]nicotine and [3H]acetylcholine binding.
    Sershen H, Reith ME, Hashim A, Lajtha A.
    J Neurosci Res; 1984 Aug; 12(4):563-9. PubMed ID: 6512887
    [Abstract] [Full Text] [Related]

  • 9. Comparison of [3H]nicotine and [3H]acetylcholine binding in mouse brain: regional distribution.
    Sershen H, Reith ME, Hashim A, Lajtha A.
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):345-52. PubMed ID: 4023418
    [Abstract] [Full Text] [Related]

  • 10. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.
    Schwartz RD, Kellar KJ.
    J Neurochem; 1985 Aug; 45(2):427-33. PubMed ID: 4009168
    [Abstract] [Full Text] [Related]

  • 11. Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
    Dunn SM, Raftery MA.
    Biochemistry; 1997 Apr 01; 36(13):3846-53. PubMed ID: 9092814
    [Abstract] [Full Text] [Related]

  • 12. Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine.
    Hulihan-Giblin BA, Lumpkin MD, Kellar KJ.
    J Pharmacol Exp Ther; 1990 Jan 01; 252(1):21-5. PubMed ID: 2299591
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
    Bencherif M, Fowler K, Lukas RJ, Lippiello PM.
    J Pharmacol Exp Ther; 1995 Nov 01; 275(2):987-94. PubMed ID: 7473192
    [Abstract] [Full Text] [Related]

  • 14. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
    Wonnacott S, Jackman S, Swanson KL, Rapoport H, Albuquerque EX.
    J Pharmacol Exp Ther; 1991 Oct 01; 259(1):387-91. PubMed ID: 1920126
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1984 Jun 01; 229(3):747-55. PubMed ID: 6202869
    [Abstract] [Full Text] [Related]

  • 16. Kinetics and mechanism of L-[3H]nicotine binding to putative high affinity receptor sites in rat brain.
    Lippiello PM, Sears SB, Fernandes KG.
    Mol Pharmacol; 1987 Apr 01; 31(4):392-400. PubMed ID: 3574288
    [Abstract] [Full Text] [Related]

  • 17. Melatonin modulation of presynaptic nicotinic acetylcholine receptors in the rat vas deferens.
    Markus RP, Zago WM, Carneiro RC.
    J Pharmacol Exp Ther; 1996 Oct 01; 279(1):18-22. PubMed ID: 8858970
    [Abstract] [Full Text] [Related]

  • 18. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.
    Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A.
    J Neurosci; 1985 May 01; 5(5):1307-15. PubMed ID: 3998824
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.
    Copeland JR, Adem A, Jacob P, Nordberg A.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb 01; 343(2):123-7. PubMed ID: 2067586
    [Abstract] [Full Text] [Related]

  • 20. Distribution of nicotinic cholinergic receptors in the rat tel- and diencephalon: a quantitative receptor autoradiographical study using [3H]-acetylcholine, [alpha-125I]bungarotoxin and [3H]nicotine.
    Härfstrand A, Adem A, Fuxe K, Agnati L, Andersson K, Nordberg A.
    Acta Physiol Scand; 1988 Jan 01; 132(1):1-14. PubMed ID: 3223299
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.